List of MeSH codes (C18)
For other categories, see List of MeSH codes.
The following is a list of the "C" codes for MeSH. It is a product of the United States National Library of Medicine.
Source for content is here. (File "2006 MeSH Trees".)
MeSH C18 --- nutritional and metabolic diseases
MeSH C18.452 --- metabolic diseases
MeSH C18.452.076 --- acid-base imbalance
- MeSH C18.452.076.087 --- achlorhydria
- MeSH C18.452.076.176 --- acidosis
- MeSH C18.452.076.176.180 --- acidosis, lactic
- MeSH C18.452.076.176.210 --- acidosis, renal tubular
- MeSH C18.452.076.176.310 --- acidosis, respiratory
- MeSH C18.452.076.176.390 --- diabetic ketoacidosis
- MeSH C18.452.076.176.652 --- ketosis
- MeSH C18.452.076.354 --- alkalosis
- MeSH C18.452.076.354.271 --- alkalosis, respiratory
MeSH C18.452.090 --- amyloidosis
- MeSH C18.452.090.050 --- amyloid neuropathies
- MeSH C18.452.090.050.050 --- amyloid neuropathies, familial
- MeSH C18.452.090.075 --- amyloidosis, familial
- MeSH C18.452.090.075.050 --- amyloid neuropathies, familial
- MeSH C18.452.090.075.160 --- cerebral amyloid angiopathy, familial
- MeSH C18.452.090.100 --- cerebral amyloid angiopathy
- MeSH C18.452.090.100.160 --- cerebral amyloid angiopathy, familial
MeSH C18.452.100 --- brain diseases, metabolic
- MeSH C18.452.100.100 --- brain diseases, metabolic, inborn
- MeSH C18.452.100.100.050 --- abetalipoproteinemia
- MeSH C18.452.100.100.162 --- carbamoyl-phosphate synthase i deficiency disease
- MeSH C18.452.100.100.175 --- citrullinemia
- MeSH C18.452.100.100.320 --- galactosemias
- MeSH C18.452.100.100.355 --- hartnup disease
- MeSH C18.452.100.100.360 --- hepatolenticular degeneration
- MeSH C18.452.100.100.365 --- homocystinuria
- MeSH C18.452.100.100.370 --- hyperargininemia
- MeSH C18.452.100.100.375 --- hyperglycinemia, nonketotic
- MeSH C18.452.100.100.380 --- hyperlysinemias
- MeSH C18.452.100.100.412 --- leigh disease
- MeSH C18.452.100.100.425 --- lesch-nyhan syndrome
- MeSH C18.452.100.100.435 --- lysosomal storage diseases, nervous system
- MeSH C18.452.100.100.435.295 --- fucosidosis
- MeSH C18.452.100.100.435.340 --- glycogen storage disease type ii
- MeSH C18.452.100.100.435.590 --- mucolipidoses
- MeSH C18.452.100.100.435.810 --- sialic acid storage disease
- MeSH C18.452.100.100.435.825 --- sphingolipidoses
- MeSH C18.452.100.100.435.825.200 --- fabry disease
- MeSH C18.452.100.100.435.825.300 --- gangliosidoses
- MeSH C18.452.100.100.435.825.300.300 --- gangliosidoses gm2
- MeSH C18.452.100.100.435.825.300.300.800 --- sandhoff disease
- MeSH C18.452.100.100.435.825.300.300.840 --- tay-sachs disease
- MeSH C18.452.100.100.435.825.300.300.920 --- tay-sachs disease, ab variant
- MeSH C18.452.100.100.435.825.300.400 --- gangliosidosis gm1
- MeSH C18.452.100.100.435.825.400 --- gaucher disease
- MeSH C18.452.100.100.435.825.590 --- leukodystrophy, globoid cell
- MeSH C18.452.100.100.435.825.594 --- leukodystrophy, metachromatic
- MeSH C18.452.100.100.435.825.700 --- niemann-pick diseases
- MeSH C18.452.100.100.520 --- maple syrup urine disease
- MeSH C18.452.100.100.535 --- melas syndrome
- MeSH C18.452.100.100.540 --- menkes kinky hair syndrome
- MeSH C18.452.100.100.545 --- merrf syndrome
- MeSH C18.452.100.100.640 --- oculocerebrorenal syndrome
- MeSH C18.452.100.100.650 --- ornithine carbamoyltransferase deficiency disease
- MeSH C18.452.100.100.680 --- peroxisomal disorders
- MeSH C18.452.100.100.680.100 --- adrenoleukodystrophy
- MeSH C18.452.100.100.680.760 --- refsum disease
- MeSH C18.452.100.100.680.970 --- zellweger syndrome
- MeSH C18.452.100.100.687 --- phenylketonurias
- MeSH C18.452.100.100.687.500 --- phenylketonuria, maternal
- MeSH C18.452.100.100.725 --- pyruvate carboxylase deficiency disease
- MeSH C18.452.100.100.750 --- pyruvate dehydrogenase complex deficiency disease
- MeSH C18.452.100.100.875 --- tyrosinemias
- MeSH C18.452.100.360 --- hepatic encephalopathy
- MeSH C18.452.100.480 --- kernicterus
- MeSH C18.452.100.540 --- mitochondrial encephalomyopathies
- MeSH C18.452.100.560 --- myelinolysis, central pontine
- MeSH C18.452.100.780 --- reye syndrome
- MeSH C18.452.100.960 --- wernicke encephalopathy
MeSH C18.452.174 --- calcium metabolism disorders
- MeSH C18.452.174.130 --- calcinosis
- MeSH C18.452.174.130.186 --- calciphylaxis
- MeSH C18.452.174.130.204 --- crest syndrome
- MeSH C18.452.174.130.560 --- nephrocalcinosis
- MeSH C18.452.174.289 --- decalcification, pathologic
- MeSH C18.452.174.451 --- hypercalcemia
- MeSH C18.452.174.509 --- hypocalcemia
- MeSH C18.452.174.509.700 --- tetany
- MeSH C18.452.174.662 --- osteomalacia
- MeSH C18.452.174.766 --- pseudohypoparathyroidism
- MeSH C18.452.174.766.815 --- pseudopseudohypoparathyroidism
- MeSH C18.452.174.845 --- rickets
MeSH C18.452.284 --- dna repair-deficiency disorders
- MeSH C18.452.284.060 --- ataxia telangiectasia
- MeSH C18.452.284.100 --- bloom syndrome
- MeSH C18.452.284.250 --- cockayne syndrome
- MeSH C18.452.284.255 --- colorectal neoplasms, hereditary nonpolyposis
- MeSH C18.452.284.280 --- fanconi anemia
- MeSH C18.452.284.520 --- li-fraumeni syndrome
- MeSH C18.452.284.600 --- nijmegen breakage syndrome
- MeSH C18.452.284.760 --- rothmund-thomson syndrome
- MeSH C18.452.284.800 --- severe combined immunodeficiency
- MeSH C18.452.284.960 --- werner syndrome
- MeSH C18.452.284.975 --- xeroderma pigmentosum
MeSH C18.452.339 --- dyslipidemias
- MeSH C18.452.339.500 --- hyperlipidemia
- MeSH C18.452.339.500.396 --- hypercholesterolemia
- MeSH C18.452.339.500.396.300 --- hypercholesterolemia, familial
- MeSH C18.452.339.500.438 --- hyperlipidemia, familial combined
- MeSH C18.452.339.500.438.390 --- hypercholesterolemia, familial
- MeSH C18.452.339.500.438.395 --- hyperlipoproteinemia type iv
- MeSH C18.452.339.500.851 --- hypertriglyceridemia
- MeSH C18.452.339.750 --- hyperlipoproteinemia
- MeSH C18.452.339.750.475 --- hypercholesterolemia, familial
- MeSH C18.452.339.750.485 --- hyperlipoproteinemia type iii
- MeSH C18.452.339.750.490 --- hyperlipoproteinemia type iv
- MeSH C18.452.339.750.495 --- hyperlipoproteinemia type v
- MeSH C18.452.339.750.552 --- lipoprotein lipase deficiency, familial
- MeSH C18.452.339.875 --- hypolipoproteinemia
- MeSH C18.452.339.875.220 --- abetalipoproteinemia
- MeSH C18.452.339.875.440 --- hypobetalipoproteinemia
- MeSH C18.452.339.875.448 --- lecithin acyltransferase deficiency
- MeSH C18.452.339.875.724 --- tangier disease
MeSH C18.452.394 --- glucose metabolism disorders
- MeSH C18.452.394.750 --- diabetes mellitus
- MeSH C18.452.394.750.074 --- diabetes mellitus, experimental
- MeSH C18.452.394.750.124 --- diabetes mellitus, type 1
- MeSH C18.452.394.750.124.960 --- wolfram syndrome
- MeSH C18.452.394.750.149 --- diabetes mellitus, type 2
- MeSH C18.452.394.750.149.500 --- diabetes mellitus, lipoatrophic
- MeSH C18.452.394.750.448 --- diabetes, gestational
- MeSH C18.452.394.750.535 --- diabetic ketoacidosis
- MeSH C18.452.394.750.774 --- prediabetic state
- MeSH C18.452.394.937 --- glycosuria
- MeSH C18.452.394.937.450 --- glycosuria, renal
- MeSH C18.452.394.952 --- hyperglycemia
- MeSH C18.452.394.952.500 --- glucose intolerance
- MeSH C18.452.394.968 --- hyperinsulinism
- MeSH C18.452.394.968.500 --- insulin resistance
- MeSH C18.452.394.968.500.570 --- metabolic syndrome x
- MeSH C18.452.394.968.750 --- persistent hyperinsulinemia hypoglycemia of infancy
- MeSH C18.452.394.984 --- hypoglycemia
- MeSH C18.452.394.984.492 --- insulin coma
- MeSH C18.452.394.984.746 --- persistent hyperinsulinemia hypoglycemia of infancy
MeSH C18.452.429 --- hyperbilirubinemia
- MeSH C18.452.429.124 --- hyperbilirubinemia, neonatal
- MeSH C18.452.429.124.500 --- jaundice, neonatal
- MeSH C18.452.429.500 --- kernicterus
MeSH C18.452.497 --- hyperoxaluria
MeSH C18.452.565 --- iron metabolism disorders
- MeSH C18.452.565.100 --- anemia, iron-deficiency
- MeSH C18.452.565.500 --- iron overload
- MeSH C18.452.565.500.480 --- hemochromatosis
- MeSH C18.452.565.500.500 --- hemosiderosis
MeSH C18.452.603 --- malabsorption syndromes
- MeSH C18.452.603.145 --- blind loop syndrome
- MeSH C18.452.603.250 --- celiac disease
- MeSH C18.452.603.506 --- lactose intolerance
- MeSH C18.452.603.850 --- sprue, tropical
- MeSH C18.452.603.887 --- steatorrhea
- MeSH C18.452.603.925 --- whipple disease
MeSH C18.452.648 --- metabolism, inborn errors
- MeSH C18.452.648.066 --- amino acid metabolism, inborn errors
- MeSH C18.452.648.066.102 --- albinism
- MeSH C18.452.648.066.102.090 --- albinism, ocular
- MeSH C18.452.648.066.102.100 --- albinism, oculocutaneous
- MeSH C18.452.648.066.102.100.400 --- hermanski-pudlak syndrome
- MeSH C18.452.648.066.102.600 --- piebaldism
- MeSH C18.452.648.066.187 --- alkaptonuria
- MeSH C18.452.648.066.210 --- aminoaciduria, renal
- MeSH C18.452.648.066.210.250 --- cystinuria
- MeSH C18.452.648.066.210.490 --- hartnup disease
- MeSH C18.452.648.066.275 --- carbamoyl-phosphate synthase i deficiency disease
- MeSH C18.452.648.066.340 --- citrullinemia
- MeSH C18.452.648.066.470 --- homocystinuria
- MeSH C18.452.648.066.475 --- hyperargininemia
- MeSH C18.452.648.066.477 --- hyperglycinemia, nonketotic
- MeSH C18.452.648.066.480 --- hyperhomocysteinemia
- MeSH C18.452.648.066.544 --- hyperlysinemias
- MeSH C18.452.648.066.608 --- maple syrup urine disease
- MeSH C18.452.648.066.620 --- multiple carboxylase deficiency
- MeSH C18.452.648.066.620.100 --- biotinidase deficiency
- MeSH C18.452.648.066.620.380 --- holocarboxylase synthetase deficiency
- MeSH C18.452.648.066.729 --- ornithine carbamoyltransferase deficiency disease
- MeSH C18.452.648.066.766 --- phenylketonurias
- MeSH C18.452.648.066.766.500 --- phenylketonuria, maternal
- MeSH C18.452.648.066.880 --- tyrosinemias
- MeSH C18.452.648.088 --- amino acid transport disorders, inborn
- MeSH C18.452.648.088.400 --- hartnup disease
- MeSH C18.452.648.088.600 --- oculocerebrorenal syndrome
- MeSH C18.452.648.100 --- amyloidosis, familial
- MeSH C18.452.648.100.050 --- amyloid neuropathies, familial
- MeSH C18.452.648.100.160 --- cerebral amyloid angiopathy, familial
- MeSH C18.452.648.151 --- brain diseases, metabolic, inborn
- MeSH C18.452.648.151.050 --- abetalipoproteinemia
- MeSH C18.452.648.151.162 --- carbamoyl-phosphate synthase i deficiency disease
- MeSH C18.452.648.151.168 --- cerebral amyloid angiopathy, familial
- MeSH C18.452.648.151.175 --- citrullinemia
- MeSH C18.452.648.151.300 --- fucosidosis
- MeSH C18.452.648.151.320 --- galactosemias
- MeSH C18.452.648.151.330 --- glycogen storage disease type ii
- MeSH C18.452.648.151.355 --- hartnup disease
- MeSH C18.452.648.151.360 --- hepatolenticular degeneration
- MeSH C18.452.648.151.365 --- homocystinuria
- MeSH C18.452.648.151.370 --- hyperargininemia
- MeSH C18.452.648.151.375 --- hyperglycinemia, nonketotic
- MeSH C18.452.648.151.380 --- hyperlysinemias
- MeSH C18.452.648.151.412 --- leigh disease
- MeSH C18.452.648.151.425 --- lesch-nyhan syndrome
- MeSH C18.452.648.151.435 --- lysosomal storage diseases, nervous system
- MeSH C18.452.648.151.435.295 --- fucosidosis
- MeSH C18.452.648.151.435.340 --- glycogen storage disease type ii
- MeSH C18.452.648.151.435.590 --- mucolipidoses
- MeSH C18.452.648.151.435.810 --- sialic acid storage disease
- MeSH C18.452.648.151.435.825 --- sphingolipidoses
- MeSH C18.452.648.151.435.825.200 --- fabry disease
- MeSH C18.452.648.151.435.825.300 --- gangliosidoses
- MeSH C18.452.648.151.435.825.300.300 --- gangliosidoses gm2
- MeSH C18.452.648.151.435.825.300.300.800 --- sandhoff disease
- MeSH C18.452.648.151.435.825.300.300.840 --- tay-sachs disease
- MeSH C18.452.648.151.435.825.300.300.920 --- tay-sachs disease, ab variant
- MeSH C18.452.648.151.435.825.300.400 --- gangliosidosis gm1
- MeSH C18.452.648.151.435.825.400 --- gaucher disease
- MeSH C18.452.648.151.435.825.590 --- leukodystrophy, globoid cell
- MeSH C18.452.648.151.435.825.594 --- leukodystrophy, metachromatic
- MeSH C18.452.648.151.435.825.700 --- niemann-pick diseases
- MeSH C18.452.648.151.445 --- maple syrup urine disease
- MeSH C18.452.648.151.447 --- melas syndrome
- MeSH C18.452.648.151.450 --- menkes kinky hair syndrome
- MeSH C18.452.648.151.505 --- merrf syndrome
- MeSH C18.452.648.151.580 --- mucolipidoses
- MeSH C18.452.648.151.640 --- oculocerebrorenal syndrome
- MeSH C18.452.648.151.650 --- ornithine carbamoyltransferase deficiency disease
- MeSH C18.452.648.151.680 --- peroxisomal disorders
- MeSH C18.452.648.151.680.100 --- adrenoleukodystrophy
- MeSH C18.452.648.151.680.760 --- refsum disease
- MeSH C18.452.648.151.680.970 --- zellweger syndrome
- MeSH C18.452.648.151.687 --- phenylketonurias
- MeSH C18.452.648.151.687.500 --- phenylketonuria, maternal
- MeSH C18.452.648.151.725 --- pyruvate carboxylase deficiency disease
- MeSH C18.452.648.151.750 --- pyruvate dehydrogenase complex deficiency disease
- MeSH C18.452.648.151.825 --- sphingolipidoses
- MeSH C18.452.648.151.825.200 --- fabry disease
- MeSH C18.452.648.151.825.300 --- gangliosidoses
- MeSH C18.452.648.151.825.300.300 --- gangliosidoses gm2
- MeSH C18.452.648.151.825.300.300.700 --- sandhoff disease
- MeSH C18.452.648.151.825.300.300.850 --- tay-sachs disease
- MeSH C18.452.648.151.825.300.300.925 --- tay-sachs disease, ab variant
- MeSH C18.452.648.151.825.300.400 --- gangliosidosis gm1
- MeSH C18.452.648.151.825.400 --- gaucher disease
- MeSH C18.452.648.151.825.590 --- leukodystrophy, globoid cell
- MeSH C18.452.648.151.825.594 --- leukodystrophy, metachromatic
- MeSH C18.452.648.151.825.700 --- niemann-pick diseases
- MeSH C18.452.648.151.875 --- tyrosinemias
- MeSH C18.452.648.202 --- carbohydrate metabolism, inborn errors
- MeSH C18.452.648.202.125 --- carbohydrate-deficient glycoprotein syndrome
- MeSH C18.452.648.202.251 --- fructose metabolism, inborn errors
- MeSH C18.452.648.202.251.221 --- fructose-1,6-diphosphatase deficiency
- MeSH C18.452.648.202.251.271 --- fructose intolerance
- MeSH C18.452.648.202.303 --- fucosidosis
- MeSH C18.452.648.202.355 --- galactosemias
- MeSH C18.452.648.202.449 --- glycogen storage disease
- MeSH C18.452.648.202.449.448 --- glycogen storage disease type i
- MeSH C18.452.648.202.449.500 --- glycogen storage disease type ii
- MeSH C18.452.648.202.449.510 --- glycogen storage disease type iib
- MeSH C18.452.648.202.449.520 --- glycogen storage disease type iii
- MeSH C18.452.648.202.449.540 --- glycogen storage disease type iv
- MeSH C18.452.648.202.449.560 --- glycogen storage disease type v
- MeSH C18.452.648.202.449.580 --- glycogen storage disease type vi
- MeSH C18.452.648.202.449.600 --- glycogen storage disease type vii
- MeSH C18.452.648.202.449.620 --- glycogen storage disease type viii
- MeSH C18.452.648.202.460 --- hyperoxaluria, primary
- MeSH C18.452.648.202.589 --- lactose intolerance
- MeSH C18.452.648.202.607 --- mannosidase deficiency diseases
- MeSH C18.452.648.202.607.500 --- alpha-mannosidosis
- MeSH C18.452.648.202.607.750 --- beta-mannosidosis
- MeSH C18.452.648.202.670 --- mucolipidoses
- MeSH C18.452.648.202.715 --- mucopolysaccharidoses
- MeSH C18.452.648.202.715.640 --- mucopolysaccharidosis i
- MeSH C18.452.648.202.715.645 --- mucopolysaccharidosis ii
- MeSH C18.452.648.202.715.650 --- mucopolysaccharidosis iii
- MeSH C18.452.648.202.715.655 --- mucopolysaccharidosis iv
- MeSH C18.452.648.202.715.670 --- mucopolysaccharidosis vi
- MeSH C18.452.648.202.715.675 --- mucopolysaccharidosis vii
- MeSH C18.452.648.202.720 --- multiple carboxylase deficiency
- MeSH C18.452.648.202.720.100 --- biotinidase deficiency
- MeSH C18.452.648.202.720.380 --- holocarboxylase synthetase deficiency
- MeSH C18.452.648.202.810 --- pyruvate metabolism, inborn errors
- MeSH C18.452.648.202.810.444 --- leigh disease
- MeSH C18.452.648.202.810.666 --- pyruvate carboxylase deficiency disease
- MeSH C18.452.648.202.810.766 --- pyruvate dehydrogenase complex deficiency disease
- MeSH C18.452.648.240 --- cytochrome-c oxidase deficiency
- MeSH C18.452.648.390 --- glucosephosphate dehydrogenase deficiency
- MeSH C18.452.648.437 --- hyperbilirubinemia, hereditary
- MeSH C18.452.648.437.281 --- crigler-najjar syndrome
- MeSH C18.452.648.437.528 --- gilbert disease
- MeSH C18.452.648.499 --- jaundice, chronic idiopathic
- MeSH C18.452.648.556 --- lipid metabolism, inborn errors
- MeSH C18.452.648.556.475 --- hypercholesterolemia, familial
- MeSH C18.452.648.556.480 --- hyperlipidemia, familial combined
- MeSH C18.452.648.556.480.390 --- hypercholesterolemia, familial
- MeSH C18.452.648.556.480.395 --- hyperlipoproteinemia type iv
- MeSH C18.452.648.556.484 --- hyperlipoproteinemia type iii
- MeSH C18.452.648.556.490 --- hyperlipoproteinemia type iv
- MeSH C18.452.648.556.495 --- hyperlipoproteinemia type v
- MeSH C18.452.648.556.500 --- hypolipoproteinemia
- MeSH C18.452.648.556.500.220 --- abetalipoproteinemia
- MeSH C18.452.648.556.500.440 --- hypobetalipoproteinemia
- MeSH C18.452.648.556.500.448 --- lecithin acyltransferase deficiency
- MeSH C18.452.648.556.500.724 --- tangier disease
- MeSH C18.452.648.556.641 --- lipoidosis
- MeSH C18.452.648.556.641.201 --- cholesterol ester storage disease
- MeSH C18.452.648.556.641.391 --- lipoidproteinosis
- MeSH C18.452.648.556.641.509 --- neuronal ceroid-lipofuscinosis
- MeSH C18.452.648.556.641.643 --- refsum disease
- MeSH C18.452.648.556.641.723 --- sjogren-larsson syndrome
- MeSH C18.452.648.556.641.803 --- sphingolipidoses
- MeSH C18.452.648.556.641.803.300 --- fabry disease
- MeSH C18.452.648.556.641.803.350 --- gangliosidoses
- MeSH C18.452.648.556.641.803.350.300 --- gangliosidoses gm2
- MeSH C18.452.648.556.641.803.350.300.700 --- sandhoff disease
- MeSH C18.452.648.556.641.803.350.300.850 --- tay-sachs disease
- MeSH C18.452.648.556.641.803.350.300.925 --- tay-sachs disease, ab variant
- MeSH C18.452.648.556.641.803.350.360 --- gangliosidosis gm1
- MeSH C18.452.648.556.641.803.441 --- gaucher disease
- MeSH C18.452.648.556.641.803.585 --- leukodystrophy, globoid cell
- MeSH C18.452.648.556.641.803.594 --- leukodystrophy, metachromatic
- MeSH C18.452.648.556.641.803.730 --- niemann-pick diseases
- MeSH C18.452.648.556.641.803.850 --- sea-blue histiocyte syndrome
- MeSH C18.452.648.556.641.923 --- wolman disease
- MeSH C18.452.648.556.645 --- lipoprotein lipase deficiency, familial
- MeSH C18.452.648.556.750 --- peroxisomal disorders
- MeSH C18.452.648.556.750.025 --- acatalasia
- MeSH C18.452.648.556.750.112 --- adrenoleukodystrophy
- MeSH C18.452.648.556.750.200 --- chondrodysplasia punctata, rhizomelic
- MeSH C18.452.648.556.750.760 --- refsum disease
- MeSH C18.452.648.556.750.970 --- zellweger syndrome
- MeSH C18.452.648.556.850 --- smith-lemli-opitz syndrome
- MeSH C18.452.648.556.925 --- xanthomatosis, cerebrotendinous
- MeSH C18.452.648.595 --- lysosomal storage diseases
- MeSH C18.452.648.595.201 --- cholesterol ester storage disease
- MeSH C18.452.648.595.554 --- lysosomal storage diseases, nervous system
- MeSH C18.452.648.595.554.295 --- fucosidosis
- MeSH C18.452.648.595.554.340 --- glycogen storage disease type ii
- MeSH C18.452.648.595.554.590 --- mucolipidoses
- MeSH C18.452.648.595.554.810 --- sialic acid storage disease
- MeSH C18.452.648.595.554.825 --- sphingolipidoses
- MeSH C18.452.648.595.554.825.200 --- fabry disease
- MeSH C18.452.648.595.554.825.300 --- gangliosidoses
- MeSH C18.452.648.595.554.825.300.300 --- gangliosidoses gm2
- MeSH C18.452.648.595.554.825.300.300.800 --- sandhoff disease
- MeSH C18.452.648.595.554.825.300.300.840 --- tay-sachs disease
- MeSH C18.452.648.595.554.825.300.300.920 --- tay-sachs disease, ab variant
- MeSH C18.452.648.595.554.825.300.400 --- gangliosidosis gm1
- MeSH C18.452.648.595.554.825.400 --- gaucher disease
- MeSH C18.452.648.595.554.825.590 --- leukodystrophy, globoid cell
- MeSH C18.452.648.595.554.825.594 --- leukodystrophy, metachromatic
- MeSH C18.452.648.595.554.825.700 --- niemann-pick diseases
- MeSH C18.452.648.595.577 --- mannosidase deficiency diseases
- MeSH C18.452.648.595.577.500 --- alpha-mannosidosis
- MeSH C18.452.648.595.577.750 --- beta-mannosidosis
- MeSH C18.452.648.595.600 --- mucopolysaccharidoses
- MeSH C18.452.648.595.600.640 --- mucopolysaccharidosis i
- MeSH C18.452.648.595.600.645 --- mucopolysaccharidosis ii
- MeSH C18.452.648.595.600.650 --- mucopolysaccharidosis iii
- MeSH C18.452.648.595.600.655 --- mucopolysaccharidosis iv
- MeSH C18.452.648.595.600.670 --- mucopolysaccharidosis vi
- MeSH C18.452.648.595.600.675 --- mucopolysaccharidosis vii
- MeSH C18.452.648.595.803 --- sphingolipidoses
- MeSH C18.452.648.595.803.300 --- fabry disease
- MeSH C18.452.648.595.803.350 --- gangliosidoses
- MeSH C18.452.648.595.803.350.300 --- gangliosidoses gm2
- MeSH C18.452.648.595.803.350.300.700 --- sandhoff disease
- MeSH C18.452.648.595.803.350.300.850 --- tay-sachs disease
- MeSH C18.452.648.595.803.350.300.925 --- tay-sachs disease, ab variant
- MeSH C18.452.648.595.803.441 --- gaucher disease
- MeSH C18.452.648.595.803.585 --- leukodystrophy, globoid cell
- MeSH C18.452.648.595.803.594 --- leukodystrophy, metachromatic
- MeSH C18.452.648.595.803.730 --- niemann-pick diseases
- MeSH C18.452.648.595.803.850 --- sea-blue histiocyte syndrome
- MeSH C18.452.648.595.923 --- wolman disease
- MeSH C18.452.648.618 --- metal metabolism, inborn errors
- MeSH C18.452.648.618.337 --- hemochromatosis
- MeSH C18.452.648.618.403 --- hepatolenticular degeneration
- MeSH C18.452.648.618.482 --- hypophosphatasia
- MeSH C18.452.648.618.544 --- hypophosphatemia, familial
- MeSH C18.452.648.618.590 --- menkes kinky hair syndrome
- MeSH C18.452.648.618.711 --- paralyses, familial periodic
- MeSH C18.452.648.618.711.550 --- hypokalemic periodic paralysis
- MeSH C18.452.648.618.711.600 --- paralysis, hyperkalemic periodic
- MeSH C18.452.648.618.815 --- pseudohypoparathyroidism
- MeSH C18.452.648.618.815.815 --- pseudopseudohypoparathyroidism
- MeSH C18.452.648.730 --- porphyria, erythropoietic
- MeSH C18.452.648.735 --- porphyrias, hepatic
- MeSH C18.452.648.735.074 --- coproporphyria, hereditary
- MeSH C18.452.648.735.150 --- porphyria, acute intermittent
- MeSH C18.452.648.735.250 --- porphyria cutanea tarda
- MeSH C18.452.648.735.437 --- porphyria, hepatoerythropoietic
- MeSH C18.452.648.735.625 --- porphyria, variegate
- MeSH C18.452.648.735.812 --- protoporphyria, erythropoietic
- MeSH C18.452.648.769 --- progeria
- MeSH C18.452.648.798 --- purine-pyrimidine metabolism, inborn errors
- MeSH C18.452.648.798.368 --- gout
- MeSH C18.452.648.798.368.410 --- arthritis, gouty
- MeSH C18.452.648.798.594 --- lesch-nyhan syndrome
- MeSH C18.452.648.851 --- renal tubular transport, inborn errors
- MeSH C18.452.648.851.093 --- acidosis, renal tubular
- MeSH C18.452.648.851.191 --- aminoaciduria, renal
- MeSH C18.452.648.851.191.250 --- cystinuria
- MeSH C18.452.648.851.191.457 --- hartnup disease
- MeSH C18.452.648.851.368 --- cystinosis
- MeSH C18.452.648.851.368.210 --- fanconi syndrome
- MeSH C18.452.648.851.532 --- glycosuria, renal
- MeSH C18.452.648.851.647 --- hypophosphatemia, familial
- MeSH C18.452.648.851.750 --- oculocerebrorenal syndrome
- MeSH C18.452.648.851.770 --- pseudohypoaldosteronism
- MeSH C18.452.648.925 --- steroid metabolism, inborn errors
- MeSH C18.452.648.925.249 --- adrenal hyperplasia, congenital
- MeSH C18.452.648.925.500 --- mineralocorticoid excess syndrome, apparent
- MeSH C18.452.648.925.750 --- ichthyosis, x-linked
- MeSH C18.452.648.925.875 --- smith-lemli-opitz syndrome
MeSH C18.452.660 --- mitochondrial diseases
- MeSH C18.452.660.195 --- cytochrome-c oxidase deficiency
- MeSH C18.452.660.300 --- friedreich ataxia
- MeSH C18.452.660.515 --- optic atrophy, hereditary, leber
- MeSH C18.452.660.520 --- leigh disease
- MeSH C18.452.660.560 --- mitochondrial myopathies
- MeSH C18.452.660.560.620 --- mitochondrial encephalomyopathies
- MeSH C18.452.660.560.620.520 --- melas syndrome
- MeSH C18.452.660.560.620.530 --- merrf syndrome
- MeSH C18.452.660.560.700 --- ophthalmoplegia, chronic progressive external
- MeSH C18.452.660.560.700.500 --- kearns-sayer syndrome
- MeSH C18.452.660.665 --- optic atrophy, autosomal dominant
- MeSH C18.452.660.705 --- pyruvate carboxylase deficiency disease
- MeSH C18.452.660.710 --- pyruvate dehydrogenase complex deficiency disease
MeSH C18.452.750 --- phosphorus metabolism disorders
MeSH C18.452.872 --- skin diseases, metabolic
- MeSH C18.452.872.077 --- adiposis dolorosa
- MeSH C18.452.872.617 --- porphyrias
- MeSH C18.452.872.617.250 --- porphyria, erythropoietic
- MeSH C18.452.872.617.400 --- porphyrias, hepatic
- MeSH C18.452.872.617.400.074 --- coproporphyria, hereditary
- MeSH C18.452.872.617.400.150 --- porphyria, acute intermittent
- MeSH C18.452.872.617.400.250 --- porphyria cutanea tarda
- MeSH C18.452.872.617.400.437 --- porphyria, hepatoerythropoietic
- MeSH C18.452.872.617.400.625 --- porphyria, variegate
- MeSH C18.452.872.617.400.812 --- protoporphyria, erythropoietic
- MeSH C18.452.872.866 --- xanthogranuloma, juvenile
- MeSH C18.452.872.929 --- xanthomatosis
- MeSH C18.452.872.929.950 --- wolman disease
- MeSH C18.452.872.929.975 --- xanthomatosis, cerebrotendinous
MeSH C18.452.940 --- wasting syndrome
MeSH C18.452.950 --- water-electrolyte imbalance
- MeSH C18.452.950.179 --- dehydration
- MeSH C18.452.950.340 --- hypercalcemia
- MeSH C18.452.950.396 --- hyperkalemia
- MeSH C18.452.950.452 --- hypernatremia
- MeSH C18.452.950.509 --- hypocalcemia
- MeSH C18.452.950.565 --- hypokalemia
- MeSH C18.452.950.620 --- hyponatremia
- MeSH C18.452.950.626 --- inappropriate adh syndrome
- MeSH C18.452.950.932 --- water intoxication
MeSH C18.654 --- nutrition disorders
MeSH C18.654.422 --- infant nutrition disorders
MeSH C18.654.521 --- malnutrition
- MeSH C18.654.521.500 --- deficiency diseases
- MeSH C18.654.521.500.133 --- avitaminosis
- MeSH C18.654.521.500.133.115 --- ascorbic acid deficiency
- MeSH C18.654.521.500.133.115.661 --- scurvy
- MeSH C18.654.521.500.133.628 --- vitamin a deficiency
- MeSH C18.654.521.500.133.699 --- vitamin b deficiency
- MeSH C18.654.521.500.133.699.160 --- choline deficiency
- MeSH C18.654.521.500.133.699.308 --- folic acid deficiency
- MeSH C18.654.521.500.133.699.529 --- pellagra
- MeSH C18.654.521.500.133.699.713 --- riboflavin deficiency
- MeSH C18.654.521.500.133.699.827 --- thiamine deficiency
- MeSH C18.654.521.500.133.699.827.223 --- beriberi
- MeSH C18.654.521.500.133.699.827.822 --- wernicke encephalopathy
- MeSH C18.654.521.500.133.699.901 --- vitamin b 6 deficiency
- MeSH C18.654.521.500.133.699.923 --- vitamin b 12 deficiency
- MeSH C18.654.521.500.133.699.923.280 --- anemia, pernicious
- MeSH C18.654.521.500.133.770 --- vitamin d deficiency
- MeSH C18.654.521.500.133.770.496 --- osteomalacia
- MeSH C18.654.521.500.133.770.734 --- rickets
- MeSH C18.654.521.500.133.841 --- vitamin e deficiency
- MeSH C18.654.521.500.133.841.682 --- steatitis
- MeSH C18.654.521.500.133.912 --- vitamin k deficiency
- MeSH C18.654.521.500.133.912.360 --- hemorrhagic disease of newborn
- MeSH C18.654.521.500.439 --- magnesium deficiency
- MeSH C18.654.521.500.617 --- potassium deficiency
- MeSH C18.654.521.500.708 --- protein deficiency
- MeSH C18.654.521.500.708.626 --- protein-energy malnutrition
- MeSH C18.654.521.500.708.626.505 --- kwashiorkor
- MeSH C18.654.521.500.857 --- swayback
- MeSH C18.654.521.625 --- fetal nutrition disorders
- MeSH C18.654.521.750 --- starvation
MeSH C18.654.726 --- overnutrition
- MeSH C18.654.726.500 --- obesity
- MeSH C18.654.726.500.695 --- obesity hypoventilation syndrome
- MeSH C18.654.726.500.700 --- obesity, morbid
- MeSH C18.654.726.500.740 --- prader-willi syndrome
MeSH C18.654.940 --- wasting syndrome
This article is issued from Wikipedia - version of the 6/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.